|
|
||||||||
1 Microbiology and Tumorbiology Center, Karolinska Institute, S-171 77 Stockholm, Sweden
2 Department of Clinical and Tumorimmunology, Daniel den Hoed Center, Rotterdam, The Netherlands
and3 Department of Cancer Studies, CRC Laboratories, University of Birmingham, UK
The six EpsteinBarr virus (EBV) nuclear antigen proteins (EBNA-16) show characteristic size variations between different virus isolates; this is a feature that has been used to identify the source of virus isolates in epidemiological studies (Ebnotyping). We have now studied the correlation between restriction fragment length polymorphisms (RFLPs) within exons coding for the EBNAs and the molecular masses of the respective proteins. The B95-8 EBV strain was used as the prototype virus. The variation in apparent molecular mass of EBNA-1, -3 and -6 correlated positively with the size of RFLP coding for repeat sequences in these polypeptides. For EBNA-2, no correlation between apparent molecular mass and length of the repetitive sequences was found. The EBNA-4 protein showed virtually no variation in apparent molecular mass and RFLP size across the repeat sequence. Based on the strong correlation between apparent molecular mass and RFLP size for EBNA-6, we developed an EBNA-6 PCR assay that discriminated between different isolates of EBV. This assay offers the advantage of EBV characterization using uncultured material (e.g. throat washings, blood or biopsies), thus avoiding the selection against poorly transforming strains that occurs during establishment of lymphoblastoid cell lines required for Ebnotyping at the protein level.
* Author for correspondence. Fax +46 8 319470. e-mail kerstin.falk@mtc.ki.se
Received 31 August 1994;
accepted 21 November 1994.
This article has been cited by other articles:
![]() |
M. Zhang and P. Coffino Repeat Sequence of Epstein-Barr Virus-encoded Nuclear Antigen 1 Protein Interrupts Proteasome Substrate Processing J. Biol. Chem., March 5, 2004; 279(10): 8635 - 8641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Walling, A. L. Brown, W. Etienne, W. A. Keitel, and P. D. Ling Multiple Epstein-Barr Virus Infections in Healthy Individuals J. Virol., June 1, 2003; 77(11): 6546 - 6550. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adler, M. Messerle, M. Wagner, and U. H. Koszinowski Cloning and Mutagenesis of the Murine Gammaherpesvirus 68 Genome as an Infectious Bacterial Artificial Chromosome J. Virol., August 1, 2000; 74(15): 6964 - 6974. [Abstract] [Full Text] |
||||
![]() |
E. Rajnavolgyi, N. Nagy, B. Thuresson, Z. Dosztanyi, A. Simon, I. Simon, R. W. Karr, I. Ernberg, E. Klein, and K. I. Falk A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4+ T lymphocytes Int. Immunol., March 1, 2000; 12(3): 281 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arens Methods for Subtyping and Molecular Comparison of Human Viral Genomes Clin. Microbiol. Rev., October 1, 1999; 12(4): 612 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Blake, A. Moghaddam, P. Rao, A. Kaur, R. Glickman, Y.-g. Cho, A. Marchini, T. Haigh, R. P. Johnson, A. B. Rickinson, et al. Inhibition of Antigen Presentation by the Glycine/Alanine Repeat Domain Is Not Conserved in Simian Homologues of Epstein-Barr Virus Nuclear Antigen 1 J. Virol., September 1, 1999; 73(9): 7381 - 7389. [Abstract] [Full Text] |
||||
![]() |
C. L. Davis, D. Field, D. Metzgar, R. Saiz, P. A. Morin, I. L. Smith, S. A. Spector, and C. Wills Numerous Length Polymorphisms at Short Tandem Repeats in Human Cytomegalovirus J. Virol., August 1, 1999; 73(8): 6265 - 6270. [Abstract] [Full Text] |
||||
![]() |
G. Habeshaw, Q. Y. Yao, A. I. Bell, D. Morton, and A. B. Rickinson Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt's Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas J. Virol., February 1, 1999; 73(2): 965 - 975. [Abstract] [Full Text] |
||||
![]() |
J. Levitskaya, A. Sharipo, A. Leonchiks, A. Ciechanover, and M. G. Masucci Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1 PNAS, November 11, 1997; 94(23): 12616 - 12621. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |